Charles Schwab’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-231,434
| Closed | -$8.09M | – | 3737 |
|
|
2024
Q1 | $8.09M | Buy |
231,434
+1,568
| +0.7% | +$54.8K | ﹤0.01% | 2089 |
|
|
2023
Q4 | $8.73M | Buy |
229,866
+17,762
| +8% | +$675K | ﹤0.01% | 2059 |
|
|
2023
Q3 | $3.89M | Sell |
212,104
-34,024
| -14% | -$624K | ﹤0.01% | 2363 |
|
|
2023
Q2 | $6.39M | Buy |
246,128
+4,427
| +2% | +$115K | ﹤0.01% | 2128 |
|
|
2023
Q1 | $4.56M | Sell |
241,701
-6,221
| -3% | -$117K | ﹤0.01% | 2246 |
|
|
2022
Q4 | $6.11M | Buy |
247,922
+26,356
| +12% | +$649K | ﹤0.01% | 2115 |
|
|
2022
Q3 | $3.98M | Buy |
221,566
+53,336
| +32% | +$958K | ﹤0.01% | 2341 |
|
|
2022
Q2 | $1.91M | Buy |
168,230
+3,700
| +2% | +$42K | ﹤0.01% | 2576 |
|
|
2022
Q1 | $3.67M | Buy |
164,530
+3,620
| +2% | +$80.7K | ﹤0.01% | 2420 |
|
|
2021
Q4 | $7.03M | Buy |
160,910
+2,825
| +2% | +$123K | ﹤0.01% | 2178 |
|
|
2021
Q3 | $5.27M | Buy |
158,085
+67,637
| +75% | +$2.25M | ﹤0.01% | 2348 |
|
|
2021
Q2 | $2.49M | Buy |
90,448
+38,950
| +76% | +$1.07M | ﹤0.01% | 2634 |
|
|
2021
Q1 | $1.03M | Buy |
51,498
+2,368
| +5% | +$47.5K | ﹤0.01% | 2842 |
|
|
2020
Q4 | $1.62M | Buy |
+49,130
| New | +$1.62M | ﹤0.01% | 2651 |
|